Introducing FAKnostic platform

The FAKnostics platform, based on our best-in-class FAK pathway inhibition methodology and diagnostic antibody technology, has the potential to serve as a prognostic tool and therapeutic program to address the unmet needs of cancer and fibrosis patients.